Friday, August 27, 2010

Combination product approved for some hypertension patients

A combination product for hypertention was recently approved by the FDA. Tribenzor, the three-in-one product, uses other hypertention drugs olmesartan medoxomil, hydrochlorothiazide, and amlodipine to relax blood vessels and allows blood to flow more freely. This combination product hopes to help those with hypertension by simplifying pill regiments, reduce the number of pills a patient takes and lower co-pay for the pills. It is hoped that this combination product will allow more individuals to reach their goal for their best blood pressure. Modern Medicine has more on the new combination product.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment